The temporal disappearance in human blood plasma of endogenous antioxidants in relation to the appearance of various classes of lipid hydroperoxides measured by HPLC postcolumn chemiluminescence detection has been investigated under two types of oxidizing conditions. Exposure of plasma to aqueous peroxyl radicals generated at a constant rate leads immediately to oxidation of endogenous ascorbate and sulfhydryl groups, followed by sequential depletion of bilirubin, urate, and o!-tocopherol. Stimulating polymorphonuclear leukocytes in plasma initiates very rapid oxidation ofascorbate, followed by partial depletion of urate. Once ascorbate is consumed completely, micromolar concentrations of hydroperoxides of plasma phospholipids, triglycerides, and cholesterol esters appear simultaneously, even though sulfhydryl groups, bilirubin, urate, and a-tocopherol are still present at high concentrations. Nonesterified fatty acids, the only lipid class in plasma not transported in lipoproteins but bound to albumin, are preserved from peroxidative damage even after complete oxidation of ascorbate, most likely due to site-specific antioxidant protection by albumin-bound bilirubin and possibly by albumin itself. Thus, in plasma ascorbate and, in a site-specific manner, bilirubin appear to be much more effective in protecting lipids from peroxidative damage by aqueous oxidants than all the other endogenous antioxidants. Hydroperoxides of linoleic acid, phosphatidylcholine, and cholesterol added to plasma in the absence of added reducing substrates are degraded, in contrast to hydroperoxides of trilinolein and cholesterol linoleate. These findings indicate the presence of a selective peroxidase activity operative under physiological conditions. Our data suggest that in states of leukocyte activation and other types of acute or chronic oxidative stress such a simple regimen as controlled ascorbate supplementation could prove helpful in preventing formation of lipid hydroperoxides, some of which cannot be detoxified by endogenous plasma activities and thus might cause damage to critical targets.
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Free radical-mediated lipid peroxidation has been proposed to be critically involved in several disease states including cancer, rheumatoid arthritis, drug-associated toxicity, and postischemic reoxygenation injury, as well as in the degenerative processes associated with aging (1) (2) (3) . Recently, evidence has accumulated suggesting that circulating lipid hydroperoxides play a pivotal role in atherogenesis (3) (4) (5) (6) and thus coronary heart disease, the single most frequent cause of death in the United States and the western world. Lipid peroxidation initiates a series of events in vitro that eventually lead to enhanced uptake of low-density lipoproteins by macrophages and formation of lipid-laden foam cells, one of the earliest atherosclerotic lesions in the arterial intima. A detailed knowledge of the mechanisms of formation and breakdown of lipid hydroperoxides in human blood plasma, therefore, could prove helpful in the understanding and preventive treatment of atherosclerosis. Also, eliminating lipid hydroperoxides in plasma before they are taken up into peripheral tissues might have a great impact on the various other diseases associated with oxidative stress.
Human plasma is endowed with an array of antioxidant defense mechanisms. Important plasma antioxidants appear to be ascorbate (7) , urate (8), a-tocopherol (9), albuminbound bilirubin (10) , and albumin itself (11) . Protein sulfhydryl groups have also been suggested to contribute significantly to the antioxidant capacity of plasma (12) , although their oxidation could also be considered oxidative damage, depending on the protein affected. Furthermore, transferrin (13) and ceruloplasmin (14) MATERIALS AND METHODS Materials. The chemicals used were the same as described (19) . In addition, bilirubin, glutathione (reduced form) (GSH), 5,5'-dithiobis(2-nitrobenzoic acid), phorbol 12-myristate 13-acetate (PMA), cytochalasin B, and sodium borohydride were purchased from Sigma. 2,2'-Azobis(2-amidinopropane) hydrochloride (AAPH) was obtained from Polysciences (Warrington, PA), and sodium borate was from Fisher. Percoll and dextran T-500 were purchased from Pharmacia. Lipid hydroperoxide standards were prepared as described (19 (10) , and plasma sulfhydryl groups were measured in 100-,ul samples with a method also described earlier (12 (22, 23) . Immediately after the addition of AAPH (time zero) and at the time points indicated, a 50-,ul and a 500-/ul aliquot were withdrawn and extracted with ice-cold methanol, and methanol followed by hexane, respectively. The methanol extract of the former sample and the hexane extract of the latter one were analyzed using HPLC with UV and chemiluminescence detection. Bilurubin was determined as described above. Plasma sulfhydryl groups (together with bilurubin as a relative standard) were measured in a separate experiment.
Incubation of Plasma with Stimulated PMNs. PMNs from 37 ml of fresh heparinized blood were isolated as described (24) , washed twice with phosphate-buffered saline, pH 7.4 (PBS) and resuspended in 0.75 ml of PBS containing 5 mM glucdse to give a final PMN concentration of -6.0 x 107 cells per ml. This step was followed by the addition of 3.45 ml of fresh plasma and 42 ug of cytochalasin B in 9 ul of dimethyl sulfoxide. After 5 min at 37°C and withdrawal of a first set of aliquots (see below) to determine the zero min values, the plasma/PMN mixture was divided into a 0.85-ml control sample, to which 1.2 pl of dimethyl sulfoxide was added and a 3.0-ml sample, to which 22 ,ug of PMA in 4.4 ,ul of dimethyl sulfoxide was added. Immediately after the addition of PMA and at the time points indicated, a 50-pul and a 200-pl aliquot were withdrawn, extracted with ice-cold methanol, and methanol followed by hexane, respectively, and analyzed as described above.
Stability of Lipid Hydroperoxides in Plasma. Lipid hydroperoxides in methanol or methanol/tert-butanol (19) were concentrated to -2 mM in a rotary evaporator under vacuum. The exact concentrations of the lipid hydroperoxides were determined by HPLC with chemiluminescence detection using linoleic acid hydroperoxide as a standard. Three milliliters of fresh plasma was incubated at 37°C for 3 min, and then =15 ,ul of the lipid hydroperoxide solution was added to give a concentration of 10.0 ,uM. Thirty seconds later and at the time points indicated, 250-,ul aliquots were withdrawn, extracted with methanol and hexane, and the two phases were analyzed. The zero-min value was obtained by adding '12.5 ,ul of the lipid hydroperoxide solution diluted 1: 10 to a mixture consisting of 0.25 ml of plasma and 1.0 ml of methanol. This step was followed by the addition of 5 ml of hexane and the normal analysis procedure.
RESULTS
To investigate the free radical-induced damage to plasma lipids and the relative effectiveness of the various plasma antioxidants in preventing this damage, we incubated fresh human blood plasma at 370C in the presence of 50 mM of the water-soluble radical initiator AAPH. Under these conditions AAPH, through thermal decomposition produces peroxyl radicals at a constant rate of 3.0 ,uM/min (22, 23 ; see also ref. 10 ). As shown in Fig. 1 (25) . As can be seen in Fig. 1 (26) . Therefore, we. added PMNs to plasma and stimulated them with PMA in the presence of cytochalasin B (27) . As shown in Fig. 2 , ascorbate was depleted very rapidly upon stimulation of PMNs with PMA. No lipid hydroperoxides could be detected during ascorbate depletion. However, once ascorbate was oxidized completely, detectable amounts of hydroperoxides of cholesterol esters, triglycerides, and phospholipids were formed simultaneously (Fig. 2) . Their identity as hydroperoxides was confirmed by elimination of their chemiluminescence response in the lipid peroxidation assay after treatment of the samples with sodium borohydride (21) (data not shown). Neither nonesterified fatty acid hydroperoxides nor cholesterol hydroperoxides could be detected in plasma incubated with activated PMNs. During the oxidation of cholesterol esters, triglycerides, and phospholipids, urate was depleted partially, whereas the levels of bilirubin and a-tocopherol remained virtually unchanged (Fig. 2) Fig. 3B ). The levels of bilirubin, urate, and a-tocopherol remained unchanged in the control experiment without PMA (the concentrations after 2 hr of incubation being 99%, 102%, and 102%, respectively, of the concentrations at the beginning of the experiment) (data not shown).
To determine the fate of lipid hydroperoxides in plasma once they have been formed or taken up into it, various lipid hydroperoxides were added to fresh plasma and incubated at 370C. Significant differences in the stability of the various lipid hydroperoxides were seen (Fig. 3A) . Whereas Fig. 1 . One experiment typical of three is shown. acid, and cholesterol were degraded. Some of the added phosphatidylcholine hydroperoxide, before being degraded, reacted with endogenous cholesterol to produce cholesterol ester hydroperoxides (0.07 ,M after 30 min of incubation), reflecting lecithin-cholesterol acyltransferase activity in plasma. The degradation of linoleic acid hydroperoxide occurred at an initial rate of 1.08 ± 0.22 ,AM/min (n = 4) as measured over the first 3 min of the experiment. The ability of plasma to degrade 10 ,M linoleic acid hydroperoxide was drastically diminished by preincubation of plasma with 50 mM AAPH for 30 min at 37°C (rate of degradation, 0.06 ,uM/min as measured over the first 15 min of the experiment). In all incubations with the various lipid hydroperoxides, the concentrations of a-tocopherol and urate remained unchanged (Fig. 3B) . The level of ascorbate decreased slowly with time (Fig. 3B) Fig. 1 that 273 ,uM lipid hydroperoxides (cholesterol ester hydroperoxides, triglyceride hydroperoxides, and phospholipid hydroperoxides) are formed between 50 and 300 min of incubation, as opposed to 750 ,uM peroxyl radicals generated during this period at a rate of 3.0 ,uM/min by decomposition of AAPH. Thus, the major portion of the peroxyl radicals generated are trapped by plasma sulfhydryl groups, urate, and a-tocopherol, causing consumption of these antioxidants; yet, concomitantly micromolar concentrations of lipid hydroperoxides are formed.
It is particularly noteworthy that in the presence of activated PMNs the plasma a-tocopherol level remains unaffected despite complete consumption of ascorbate and subsequent lipid peroxidation (see Fig. 2 ). These observations exclude the possibility that the lack of measurable a-tocopherol oxidation is due to sparing of a-tocopherol by ascorbate. Our results with both AAPH and activated PMNs indicate that in plasma a-tocopherol is considerably less effective in preventing peroxidative damage to lipids induced by aqueous oxidants than in isolated low-density lipoproteins, where atocopherol has been reported to very effectively prevent lipid peroxidation (29) . It is, therefore, conceivable that in plasma the main target of lipid peroxidation initiated by aqueous oxidants are not the lipids in the lipoproteins but those transported by transfer proteins between the lipoproteins.
The lipids bound to transfer proteins can be expected to be more directly exposed to oxidants generated outside the lipoproteins and also to be less protected by a-tocopherol.
Taken together, our results strongly suggest that ascorbate plays a pivotal role in protecting plasma lipids from peroxidative damage initiated either by aqueous peroxyl radicals or by activated PMNs. Indeed, when the experiment described in Fig. 2 was performed with plasma from an individual whose plasma ascorbate concentration was very high (140 tLM) due to dietary vitamin C supplementation, ascorbate depletion upon PMN stimulation was incomplete and no lipid hydroperoxides could be detected during the 2-hr incubation. Antioxidant protection of lipids by ascorbate in vivo should be even more extensive due to recycling of dehydroascorbate, the oxidation product of ascorbate. Dehydroascorbate appears to be taken up by erythrocytes, reduced to ascorbate by intracellular NADH and GSH, and then released again (30) . Because ascorbate is the plasma antioxidant to become oxidized immediately upon leukocyte stimulation, an increased ratio of dehydroascorbate to ascorbate might be of diagnostic use as an early indicator of oxidative stress in vivo (31) . Furthermore, a decrease in the ratio of urate to its oxidation product allantoin (32) would be indicative of sustained oxidative stress and would suggest that lipid hydroperoxides have been formed (see Fig. 2 ). Our findings also imply that ascorbate could prove helpful in the prevention and treatment of diseases and degenerative processes that may be associated with oxidative stress, such as cancer, atherosclerosis, rheumatoid arthritis, and aging, as well as in many clinical conditions characterized by generalized PMN activation, such as shock, sepsis, and trauma. Thus, our data provide evidence for an important role of ascorbate in human health and longevity beyond its well established functions in metabolism.
Exposure of plasma to either AAPH or stimulated PMNs results in different patterns of oxidation of the various antioxidants (compare Figs. 1 and 2 ). Besides the difference in a-tocopherol oxidation mentioned above, activation of PMNs does not lead to considerable oxidation of bilirubin, whereas bilirubin can trap the peroxyl radicals produced by AAPH (see also ref. 10 ). Quantitative differences were also observed: plasma ascorbate becomes much more rapidly oxidized when challenged by the oxidants released from activated PMNs than by AAPH, despite a drastically lower rate of subsequent lipid peroxidation. These differences suggest that the effects of activated PMNs on plasma antioxidants and lipids are not caused ultimately by peroxyl radicals. A more likely candidate is the myeloperoxidasederived oxidant hypochlorous acid (26) , which is known to be scavenged by ascorbate (33) and urate (34) , but not by albumin-bound bilirubin (35) . Hypochlorous acid may also be able to initiate lipid peroxidation (36) .
Our observations that hydroperoxides of free fatty acids, phospholipids, and cholesterol, but not cholesterol esters and triglycerides, are degraded in plasma suggest the presence of a selective peroxidase activity. It is conceivable that the degradation of phospholipid hydroperoxides is due to the consecutive action of the phospholipase A2 activity associated with low-density lipoproteins (4) and the peroxidase activity that subsequently reduces the liberated fatty acid hydroperoxides. A plasma glutathione peroxidase different from the erythrocyte glutathione peroxidase has been purified and characterized recently (17, 18) . The plasma glutathione peroxidase was found to have an apparent Km value for GSH of between 4.3 mM (18) and 5.3 mM (17), which is more than 104 times the steady-state level of GSH in human plasma (37) . Accordingly, no peroxidase activity was observed in plasma unless it was supplemented in vitro with exogenous GSH (16). In contrast, we find that selected lipid hydroperoxides are degraded in plasma in the absence of added reducing substrates. However, when we measured the degradation of 10 gM linoleic acid hydroperoxide using our chemiluminescence assay but the experimental conditions described in ref. 16-i.e., 20% plasma incubated for 3 min at 370C, we, too, failed to observe statistically significant degradation of the peroxidic substrate. Compatible with our observation, Terao et al. (38) recently reported that arachidonic acid hydroperoxide is reduced to the corresponding alcohol in plasma in the absence of added reducing substrates. Because the GSH level of isolated plasma is only -0.34 ,uM (37) , and we observe virtually complete degradation of 10 ,tM selected lipid hydroperoxides, it is very unlikely that this hydroperoxide degrading activity is the plasma glutathione peroxidase, unless its Km value for GSH in plasma is much lower than reported for the isolated enzyme and oxidized glutathione is recycled by (an)other reducing substrate(s) present in plasma. Such possibilities require further investigation.
